VetMedUni biopharmaceutical spinout Marinomed Biotech has completed its IPO to attain a market cap of $109m.
Marinomed Biotech, an Austria-based biopharmaceutical spinout of University of Veterinary Medicine Vienna (VetMedUni), has completed its initial public offering (IPO) on the Vienna Stock Exchange at a market capitalisation of €95.1m ($109m), MondoVisione reported on Friday. Shares were priced at $86.40 each, slightly higher than the $85.80 target, which had been expected to raise $25.6m…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
